Fentanyl versus Dexmedetomidine as Adjuvant to Intrathecal Bupivacaine

Comparative Study between Fentanyl versus Dexmedetomidine as Adjuvant to Intrathecal Bupivacaine in Lower Abdominal Surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202503471801855

Enrollment

150

Registered

2025-03-10

Start date

2024-08-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Anaesthesia

Interventions

group D

group F

group C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age range falling between 21 and 50 years admitted for elective lower abdominal surgical procedures

Exclusion criteria

Exclusion criteria: age range less than 21 or more than 50 years patients admitted for any reason other than elective lower abdominal surgical procedures

Design outcomes

Primary

Measure	Time frame
Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with five µg dexmedetomidine in 0.5 mL of normal saline within group D;Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with twenty-five µg fentanyl (0.5 ml) within group F;Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with normal saline (0.5 mL) within group C as control	—

Measure

Time frame

Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with five µg dexmedetomidine in 0.5 mL of normal saline within group D;Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with twenty-five µg fentanyl (0.5 ml) within group F;Participants underwent an equal categorization into three groups: all had intrathecally three mL volume of 0.5% hyperbaric bupivacaine, along with normal saline (0.5 mL) within group C as control

—

Secondary

Measure	Time frame
Heart rate	—

Countries

Egypt

Contacts

Public ContactMedhat Helaly Allam

Lecturer of Anesthesiology

medhathelaly@gmail.com0021003012989

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026